Quanterix Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$66M
Industry:Biotech
Founded:2007
Lead Investor(s):T. Rowe Price Associates, Inc.
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Quanterix's estimated annual revenue is currently $37.6M per year.
  • Quanterix received $8.5M in venture funding in August 2017.
  • Quanterix's estimated revenue per employee is $156,800
  • Quanterix's total funding is $66M.

Employee Data

  • Quanterix has 240 Employees.
  • Quanterix grew their employee count by 22% last year.
  • Quanterix currently has 23 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ohana Bioscienc...
$7.1M4659%N/A
Tango Therapeut...
$9M5841%N/A
Compass Therape...
$15.8M10215%N/A
Cell Signaling ...
$75.6M488N/AN/A
Momenta Pharmac...
N/A212N/AN/A
Emulate
$14.7M95-17%N/A
ArQule
N/A90N/AN/A
Hamilton Storag...
$14.6M949%N/A
Alnylam Pharmac...
$74.9M122831%N/A
Transgenomic
N/A45N/AN/A
Missing a competitor? Contribute!?
Submit

Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra-sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix technology is designed to enable much earlier disease detection, better prognosis and precise treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Lexington, Massachusetts.

keywords:Analytics,Biotechnology,Enterprise Software,Healthcare,Medical Diagnostics,Pharmaceuticals

240

Number of Employees

$37.6M

Revenue (est)

23

Current Jobs

22%

Employee Growth %

$66M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Executive Contacts

NameTitleEmail
John FryGeneral Counsel And Corporation SecretaryEmail Available
David HanlonVice President, Strategic CollaborationsEmail Available
Mark RoskeySVP Commercial & AssaysEmail Available
Scott CannistraroManager Of Technical SupportEmail Available
Robert BunzelAccount Manager
Ry Strohm-HermanAssociate Director Of It
Paul DietzAssociate Director, Design EngineeringEmail Available
Marissa SweazyVp, Public RelationsEmail Available
Shawn StetsonDirector, Corporate ControllerEmail Available
Ray MeyerPrincipal Opto-Mechanical EngineerEmail Available

Quanterix News

09/03/2019 - Quanterix Corp (NASDAQ:QTRX) CEO Sells $87,311.14 in Stock

Quanterix Corp (NASDAQ:QTRX) CEO E Kevin Hrusovsky sold 3,362 shares of the firm's stock in a transaction that occurred on Wednesday, ...

09/08/2019 - Alambic Investment Management L.P. Buys 1,739 Shares of Quanterix Corp (NASDAQ:QTRX)

Alambic Investment Management L.P. grew its stake in shares of Quanterix Corp (NASDAQ:QTRX) by 12.7% during the 2nd quarter, according ...

09/03/2019 - GSA Capital Partners LLP Makes New Investment in Quanterix Corp (NASDAQ:QTRX)

GSA Capital Partners LLP bought a new position in shares of Quanterix Corp (NASDAQ:QTRX) in the 2nd quarter, according to the company in ...

Quanterix Funding

DateAmountRoundLead InvestorsReference
2008-08-26$15.0MAARCH Venture Partners, Bain Capital VenturesArticle
2016-03-24$46.0MDARCH Overage FundArticle
2017-08-04$8.5MUndisclosedT. Rowe Price Associates, Inc.Article

Quanterix Executive Hires

DateNameTitleReference
2009-09-03Nicholas NaclerioChairmanArticle
2011-09-20Martin MadausCEOArticle
2012-07-23Paul ChapmanPresident/CEOArticle
2014-06-11Kevin HrusovskyExecutive ChairmanArticle
2014-09-17Mark RoskeyVP/GM Applications/ReagentsArticle
2017-08-04Joe DriscollCFOArticle
2019-03-29Amol ChaubalCFOArticle